Product Code: ETC8277746 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Ehlers-Danlos Syndrome Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Ehlers-Danlos Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Ehlers-Danlos Syndrome Market - Industry Life Cycle |
3.4 Mexico Ehlers-Danlos Syndrome Market - Porter's Five Forces |
3.5 Mexico Ehlers-Danlos Syndrome Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Mexico Ehlers-Danlos Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Ehlers-Danlos Syndrome (EDS) in Mexico |
4.2.2 Growing healthcare infrastructure and access to specialized care for EDS patients |
4.2.3 Rising research and development activities focused on EDS treatments |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of specialized EDS treatments in Mexico |
4.3.2 Lack of trained healthcare professionals and specialists in managing EDS cases |
4.3.3 Challenges in accurate and timely diagnosis of EDS due to its complex nature |
5 Mexico Ehlers-Danlos Syndrome Market Trends |
6 Mexico Ehlers-Danlos Syndrome Market, By Types |
6.1 Mexico Ehlers-Danlos Syndrome Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Mexico Ehlers-Danlos Syndrome Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Mexico Ehlers-Danlos Syndrome Market Revenues & Volume, By ACER 002, 2021- 2031F |
6.1.4 Mexico Ehlers-Danlos Syndrome Market Revenues & Volume, By Enzastaurin, 2021- 2031F |
7 Mexico Ehlers-Danlos Syndrome Market Import-Export Trade Statistics |
7.1 Mexico Ehlers-Danlos Syndrome Market Export to Major Countries |
7.2 Mexico Ehlers-Danlos Syndrome Market Imports from Major Countries |
8 Mexico Ehlers-Danlos Syndrome Market Key Performance Indicators |
8.1 Average time taken for EDS diagnosis in Mexico |
8.2 Number of healthcare facilities offering specialized EDS care |
8.3 Percentage of EDS patients receiving appropriate treatment and management |
8.4 Patient satisfaction levels with EDS healthcare services |
8.5 Research funding allocated to EDS studies in Mexico |
9 Mexico Ehlers-Danlos Syndrome Market - Opportunity Assessment |
9.1 Mexico Ehlers-Danlos Syndrome Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Mexico Ehlers-Danlos Syndrome Market - Competitive Landscape |
10.1 Mexico Ehlers-Danlos Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Mexico Ehlers-Danlos Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |